CastaƱares, Ethel Jane .
HRN: 22-25-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2025
CEFUROXIME 500MG (TAB)
11/26/2025
12/02/2025
PO
500 Mg
BID
Sp 1 LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes